Cargando…
Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?
Small cell lung cancer (SCLC) is treated primarily with combination chemotherapy. Despite high initial response rates, most patients eventually die with drug resistant disease. In some tumours, resistance to multiple chemotherapeutic agents is attributed to overexpression of P-glycoprotein (P-gp). H...
Autores principales: | Campling, B. G., Baer, K., Baker, H. M., Lam, Y. M., Cole, S. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968549/ https://www.ncbi.nlm.nih.gov/pubmed/8102244 |
Ejemplares similares
-
Chemosensitivity testing of small cell lung cancer using the MTT assay.
por: Campling, B. G., et al.
Publicado: (1991) -
Glutathione and related enzyme activity in human lung cancer cell lines.
por: Carmichael, J., et al.
Publicado: (1988) -
The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
por: Meijer, C., et al.
Publicado: (1990) -
Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2019) -
The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
por: Mistry, P., et al.
Publicado: (1991)